Rapid Micro Biosystems, Inc. - Class A Common Stock (RPID)

0.7353
+0.00 (0.00%)
NASDAQ · Last Trade: Nov 20th, 5:09 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.7353
Open-
Bid0.6000
Ask0.7500
Day's RangeN/A - N/A
52 Week Range0.5801 - 4.940
Volume0
Market Cap114.36M
PE Ratio (TTM)-0.6624
EPS (TTM)-1.1
Dividend & YieldN/A (N/A)
1 Month Average Volume1,071,961

Chart

About Rapid Micro Biosystems, Inc. - Class A Common Stock (RPID)

Rapid Micro Biosystems Inc. is a biotechnology company that specializes in providing innovative solutions for microbial detection in the pharmaceutical and biotechnology industries. The company focuses on developing advanced technologies that improve the efficiency and accuracy of microbial testing, which is critical for ensuring product safety and compliance with regulatory standards in manufacturing processes. By leveraging automated systems and cutting-edge software, Rapid Micro Biosystems aims to enhance the quality control measures of its clients, helping them to accelerate their manufacturing timelines and reduce operational costs. Ultimately, the company is dedicated to advancing microbial testing methodologies to support a safer and more reliable production environment for its customers. Read More

News & Press Releases

Halper Sadeh LLC is Investigating Whether AYTU, RPID, TRMK, ICMB are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 
By Halper Sadeh LLC · Via GlobeNewswire · November 18, 2026
Nasdaq Unusual Volume Movers Today: LICN, GP and CSAI Post Sharp Moveschartmill.com
Via Chartmill · November 17, 2026
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Aytu BioPharma, Inc. (Nasdaq – AYTU), Rapid Micro Biosystems, Inc. (Nasdaq – RPID), Advantage Energy Ltd. (OTC – AAVVF), Canaccord Genuity Group Inc. (OTC – CCORF)
BALA CYNWYD, Pa., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · November 17, 2026
RPID Stock Alert: Halper Sadeh LLC is Investigating Whether Rapid Micro Biosystems, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Rapid Micro Biosystems, Inc. (NASDAQ: RPID) to Merck KGaA, Darmstadt, Germany for $0.75 per share.
By Halper Sadeh LLC · Via Business Wire · November 16, 2026
Rapid Micro Biosystems (NASDAQ:RPID) Slips on Wider Q2 Loss as Revenue Matches Estimateschartmill.com
Via Chartmill · August 7, 2026
Rapid Micro Biosystems Inc-A (NASDAQ:RPID) Q1 2026: Revenue Beats Street, But EPS Miss Clouds Outlookchartmill.com
Via Chartmill · May 13, 2026
Rapid Micro Biosystems Inc (NASDAQ:RPID) Reports Record Q4 Revenue but Misses Estimates, Shares Drop 9%chartmill.com
Via Chartmill · March 12, 2026
Earnings Outlook For Rapid Micro Biosystemsbenzinga.com
Via Benzinga · November 6, 2025
RPID Shareholder Alert: ADEMI LLP Investigates Whether Buyout Fairly Values Rapid Micro Biosystems, Inc.
RPID shareholders will receive just $0.75 per share in an all-cash transaction; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers
By Ademi LLP · Via GlobeNewswire · November 16, 2026
Friday's pre-market session: top gainers and loserschartmill.com
Via Chartmill · October 2, 2026
Rapid Micro Biosystems (RPID) Q2 2026 Earnings Call Transcriptfool.com
Record gross margins and 200th system milestone signal momentum toward profitability.
Via The Motley Fool · August 14, 2026
Rapid Micro Biosystems Q2 Earnings Call Highlightsmarketbeat.com
Rapid Micro Biosystems (NASDAQ:RPID) reported second-quarter revenue of $8.1 million, up 11% from $7.3 million a year earlier and above the company’s prior guidance, as consumable sales, service activity and recurring revenue increased. The company placed four Growth Direct Systems during the quart
Via MarketBeat · August 7, 2026
A Look Ahead: Rapid Micro Biosystems's Earnings Forecastbenzinga.com
Via Benzinga · August 11, 2025
Rapid Micro Biosystems's Earnings Outlookbenzinga.com
Via Benzinga · May 8, 2025
Rapid Micro (RPID) Q1 2026 Earnings Transcriptfool.com
Rapid Micro (RPID) Q1 2026 Earnings Transcript
Via The Motley Fool · May 14, 2026
Rapid Micro Biosystems Q1 Earnings Call Highlightsmarketbeat.com
Rapid Micro Biosystems (NASDAQ:RPID) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while management said gross margin improvement remains a central priority for the year. President and Chief
Via MarketBeat · May 14, 2026
Rapid Micro (RPID) Earnings Call Transcriptfool.com
Rapid Micro (RPID) Earnings Call Transcript
Via The Motley Fool · March 12, 2026
Discover the top movers in Thursday's pre-market session.chartmill.com
Via Chartmill · March 12, 2026
These stocks are moving in today's after hours sessionchartmill.com
Via Chartmill · January 13, 2026
Rapid Micro Biosystems Inc-A (NASDAQ:RPID) Posts Mixed Q3 2025 Results, Raises Full-Year Guidancechartmill.com
Rapid Micro Biosystems posts mixed Q3 2025 results, missing estimates but raising full-year guidance after securing a major new customer order.
Via Chartmill · November 7, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · September 22, 2025
Earnings Scheduled For November 7, 2025benzinga.com
Via Benzinga · November 7, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · August 12, 2025
Earnings Scheduled For August 12, 2025benzinga.com
Via Benzinga · August 12, 2025
Earnings Scheduled For May 9, 2025benzinga.com
Via Benzinga · May 9, 2025